Actionable news
0
All posts from Actionable news
Actionable news in AAVL: AVALANCHE BIOTECHNOLOGIES INC,

Avalanche Biotechnologies to Present at Upcoming Scientific Meetings

Avalanche Biotechnologies, Inc. AAVL, -0.70% a gene therapy company committed to discovering and developing novel medicines for patients suffering from diseases with few or burdensome treatment options, announced today that in May, it and its research partner Regeneron will present at the Association for Research in Vision and Ophthalmology (ARVO) 2016 Annual Meeting in Seattle, as well as at the American Society of Gene & Cell Therapy (ASGCT) 19 [th] Annual Meeting in Washington, DC.

ARVO 2016 Annual Meeting
May 1-5, Seattle

Presentation Session #266 Room 615/617Monday, May 2, 3:45 p.m. - 5:30 p.m. PT

Intraocular Gene Expression and Functional Safety Evaluation Following Intravitreal Delivery of Cone Specific GFP-Expressing AAV Vectors in Nonhuman PrimatesPresenter: Kathryn Woodburn, PhD, Avalanche Biotechnologies, Inc.

Poster Session # 141Sunday, May 1, 1:30 p.m. - 3:15 p.m. PT

Presentation # 781
Temporal Expression...


More